Nuwellis (NUWE) Revenue Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 4.63% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 8.01% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 5.28% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 15.36% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.52% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 0.73% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 17.14% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 2.92% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 7.43% |
| 10 | Nuwellis | 1.45 Mn | -630,292.49 | 1.68 Mn | 9.58% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 9.58% |
| Dec 31, 2025 | 1.20% |
| Sep 30, 2025 | 2.40% |
| Jun 30, 2025 | -7.97% |
| Mar 31, 2025 | -0.38% |
| Dec 31, 2024 | 12.24% |
| Sep 30, 2024 | 8.50% |
| Jun 30, 2024 | -4.36% |
| Mar 31, 2024 | -1.07% |
| Dec 31, 2023 | 7.67% |
| Sep 30, 2023 | 8.20% |
| Jun 30, 2023 | 3.66% |
| Mar 31, 2023 | 3.86% |
| Dec 31, 2022 | 19.61% |
| Sep 30, 2022 | 18.15% |
| Jun 30, 2022 | 9.69% |
| Mar 31, 2022 | 16.60% |
| Dec 31, 2021 | 3.08% |
| Sep 30, 2021 | 10.78% |
| Jun 30, 2021 | 31.66% |
| Mar 31, 2021 | 22.75% |
| Dec 31, 2020 | 34.99% |
| Sep 30, 2020 | 25.77% |
| Jun 30, 2020 | 29.19% |
| Mar 31, 2020 | 21.85% |
| Dec 31, 2019 | 22.37% |
| Sep 30, 2019 | 32.11% |
| Mar 31, 2018 | 160.00% |
| Dec 31, 2017 | 67.45% |
| Sep 30, 2017 | 153.14% |
| Mar 31, 2017 | 148.10% |
| Sep 30, 2016 | 109.56% |